Voyager Therapeutics (VYGR)
NASDAQ:VYGR

Voyager Therapeutics (VYGR) Stock Forecast & Price Target

407 Followers
See the Price Targets and Ratings of:

VYGR Analyst Ratings

Moderate Buy
2Ratings
1 Buy
1 Hold
0 Sell
Based on 2 analysts giving stock ratings to
Voyager
Therapeutics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

VYGR Stock 12 Months Forecast

Average Price Target

$9.00
▲(62.45% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for Voyager Therapeutics in the last 3 months. The average price target is $9.00 with a high forecast of $9.00 and a low forecast of $9.00. The average price target represents a 62.45% change from the last price of $5.54.
Highest Price Target$9.00Average Price Target$9.00Lowest Price Target$9.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Upgrade Banner
Eight Capital
$12.69
Buy
128.97%
Upside
Reiterated
Voyager Digital has target trimmed by Eight CapitalCiting figures from theblockcrypto.com and coinmarketcap.com, Kadve noted that cryptocurrency has gone off a cliff in the most recent calendar quarter, punctuated by a 40 per cent decline in crypto trading volumes and a 27 per cent drop in the average cryptocurrency market cap.
Raymond James
Hold
Reiterated
Raymond James reiterates Market Perform Rating on Voyager Therapeutics (VYGR)
Chardan Capital
$6.00
Hold
8.30%
Upside
Reiterated
Chardan Capital Reiterates a Hold Rating on Voyager Therapeutics (VYGR)
Canaccord Genuity
$10.00
Buy
80.51%
Upside
Reiterated
Voyager Therapeutics (VYGR) PT Raised to $10 at Canaccord GenuityCanaccord Genuity analyst Sumant Kulkarni raised the price target on Voyager Therapeutics (NASDAQ: VYGR) to $10.00 (from $6.00) while maintaining a Buy rating.
Wedbush
$4.00
Hold
-27.80%
Downside
Reiterated
Voyager Therapeutics (VYGR) PT Raised to $4 at WedbushWedbush analyst Laura Chico raised the price target on Voyager Therapeutics (NASDAQ: VYGR) to $4.00 (from $3.00) while maintaining a Neutral rating.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

VYGR Financial Forecast

VYGR Earnings Forecast
Next quarter’s earnings estimate for VYGR is -$0.59 with a range of -$0.75 to -$0.38. The previous quarter’s EPS was $0.45. VYGR beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.49% of the time in the same period. In the last calendar year VYGR has Underperformed its overall industry.
Next quarter’s earnings estimate for VYGR is -$0.59 with a range of -$0.75 to -$0.38. The previous quarter’s EPS was $0.45. VYGR beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.49% of the time in the same period. In the last calendar year VYGR has Underperformed its overall industry.
VYGR Sales Forecast
Next quarter’s sales forecast for VYGR is $2.02M with a range of $0.00 to $11.00M. The previous quarter’s sales results were $41.09M. VYGR beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 42.83% of the time in the same period. In the last calendar year VYGR has Outperformed its overall industry.
Next quarter’s sales forecast for VYGR is $2.02M with a range of $0.00 to $11.00M. The previous quarter’s sales results were $41.09M. VYGR beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 42.83% of the time in the same period. In the last calendar year VYGR has Outperformed its overall industry.
VYGR Analyst Recommendation Trends
In the current month, VYGR has received 1 Buy ratings 1 Hold ratings, and 0 Sell ratings. The VYGR average analyst price target in the past 3 months is $9.00
In the current month, VYGR has received 1 Buy ratings 1 Hold ratings, and 0 Sell ratings. The VYGR average analyst price target in the past 3 months is $9.00

VYGR Stock Forecast FAQ

What is VYGR’s average 12-month price target, according to analysts?
Based on analyst ratings, Voyager Therapeutics’s 12-month average price target is $9.00.
    What is VYGR’s upside potential, based on the analysts’ average price target?
    Voyager Therapeutics has 62.45% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is VYGR a Buy, Sell or Hold?
          Voyager Therapeutics has a conensus rating of Moderate Buy which is based on 1 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Voyager Therapeutics’s price target?
            The average price target for Voyager Therapeutics is $9.00. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $9.00 ,the lowest forecast is $9.00. The average price target represents 62.45% Increase from the current price of $5.54.
              What do analysts say about Voyager Therapeutics?
              Voyager Therapeutics’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis